CarsonAllaria Wealth Management’s ExxonMobil XOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,631
Closed -$317K 72
2025
Q4
$317K Sell
2,631
-123
-4% -$14.3K 0.16% 49
2025
Q3
$310K Buy
2,754
+218
+9% +$24.2K 0.16% 48
2025
Q2
$273K Buy
2,536
+3
+0.1% +$321 0.15% 51
2025
Q1
$301K Buy
2,533
+34
+1% +$3.76K 0.17% 46
2024
Q4
$269K Sell
2,499
-350
-12% -$40.9K 0.15% 53
2024
Q3
$334K Sell
2,849
-234
-8% -$27K 0.19% 45
2024
Q2
$355K Sell
3,083
-424
-12% -$49.4K 0.22% 42
2024
Q1
$408K Sell
3,507
-365
-9% -$38.2K 0.26% 41
2023
Q4
$387K Sell
3,872
-20
-0.5% -$2.1K 0.28% 40
2023
Q3
$458K Sell
3,892
-26
-0.7% -$2.85K 0.37% 32
2023
Q2
$420K Sell
3,918
-119
-3% -$13K 0.33% 36
2023
Q1
$443K Sell
4,037
-58
-1% -$6.42K 0.37% 37
2022
Q4
$452K Buy
4,095
+67
+2% +$7.18K 0.4% 36
2022
Q3
$352K Buy
4,028
+97
+2% +$8.86K 0.33% 36
2022
Q2
$337K Sell
3,931
-165
-4% -$14.9K 0.31% 39
2022
Q1
$338K Sell
4,096
-117
-3% -$9.1K 0.3% 42
2021
Q4
$258K Buy
+4,213
New +$263K 0.23% 53

Other funds holding XOM

CarsonAllaria Wealth Management's XOM Position: Q1 2026 in Review

CarsonAllaria Wealth Management sold out of ExxonMobil (XOM) in Q1 2026, closing a stake of 2,631 shares — an estimated $317K sold.

CarsonAllaria Wealth Management first reported a position in XOM in Q4 2021 and held it in 17 quarters. The position peaked at $458K in Q3 2023. 4,762 funds tracked by Wall St. Rank hold XOM as of Q1 2026.

  • CarsonAllaria Wealth Management reported no remaining ExxonMobil position as of Q1 2026 after selling out during the quarter.
  • CarsonAllaria Wealth Management sold 2,631 ExxonMobil shares in Q1 2026, an estimated $317K.
  • CarsonAllaria Wealth Management first reported a position in ExxonMobil in Q4 2021 and held it in 17 quarters.
  • CarsonAllaria Wealth Management's ExxonMobil position peaked at $458K in Q3 2023.
  • 4,762 funds tracked by Wall St. Rank held ExxonMobil as of Q1 2026.

Based on CarsonAllaria Wealth Management's 13F filing for Q1 2026, filed 30 Apr 2026.